Continuous glucose monitor and oral glucose tolerance test for blood sugar health
Part of Hormones & metabolism clinical trials.
This study uses a continuous glucose monitor (CGM) and an oral glucose tolerance test (OGTT) to check how well your body controls blood sugar. It is for people who may have early signs of diabetes or are at risk and want to better understand their glucose health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have symptoms like unusual thirst, hunger, frequent urination, or weight loss, and a doctor suggested a glucose test.
- Or you have had slightly high fasting blood sugar (between 6.1 and 6.9 mmol/L) or a hemoglobin A1c of 5.7% to 6.4%.
- Or you have at least one risk factor for diabetes: a BMI of 24 or higher, a parent or sibling with diabetes, or high blood pressure or high cholesterol.
- You have not been diagnosed with diabetes before.
- You are not taking certain diabetes medications or steroids, and you have no serious liver or kidney problems.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how well periodic continuous glucose monitoring works for adults with type 2 diabetes. You may be asked to wear a sensor that tracks glucose more often than finger-stick checks, which can help improve day-to-day glucose control.
This study gives continuous glucose monitors (CGMs) to people with type 2 diabetes who cannot afford them. It looks at whether using a CGM helps improve blood sugar control.
This study checks whether using a continuous glucose monitor (CGM, a sensor that tracks blood sugar) is practical and helpful for people with type 2 diabetes in primary care settings. It focuses on people who may have a harder time getting diabetes support and have higher A1c levels.
This real-world study tests whether using a continuous glucose monitor (isCGM) with or without pharmacist coaching helps people with type 2 diabetes who are not on insulin improve their blood sugar control. It compares these approaches to standard blood sugar checking and looks for better HbA1c results after three months.
This trial is testing whether using a continuous glucose monitor (CGM) for different lengths of time helps people with type 2 diabetes understand their blood sugar patterns. You won't need to change your current diabetes medications.
This trial studies how well a continuous glucose monitor (a sensor that tracks glucose) works for managing blood sugar in adults with type 1 or type 2 diabetes. You may need to wear sensors and have glucose levels adjusted during clinic visits to test safety and effectiveness.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.